Find Clinical Trial

Phase I dose-escalation study of S 81694 administered intravenously in adult patients with advanced/metastatic solid tumors


← Back
Study Phase

Phase 1

Therapeutic Area

Cancers

Active substance/
Medical device

S081694

SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS081694
Protocol CodeCL1-81694-001
EudraCT Code2014-002023-10
ISRCTN CodeISRCTN35641359


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility